Oxford Biomedica Solutions
Pharmaceuticals, 400 Oser Ave, Bedford, Massachusetts, United States, 51-200 Employees
Phone Number: +14*********
Who is OXFORD BIOMEDICA SOLUTIONS
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (Oxford...
Read More
-
Headquarters: 400 Oser Ave, Bedford, Massachusetts, United States
-
Date Founded: 2022
-
Employees: 51-200
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from OXFORD BIOMEDICA SOLUTIONS
Oxford Biomedica Solutions Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Oxford Biomedica Solutions
Answer: Oxford Biomedica Solutions's headquarters are located at 400 Oser Ave, Bedford, Massachusetts, United States
Answer: Oxford Biomedica Solutions's phone number is +14*********
Answer: Oxford Biomedica Solutions's official website is https://oxbsolutions.com
Answer: Oxford Biomedica Solutions's revenue is $100 Million to $250 Million
Answer: Oxford Biomedica Solutions's SIC: 2834
Answer: Oxford Biomedica Solutions has 51-200 employees
Answer: Oxford Biomedica Solutions is in Pharmaceuticals
Answer: Oxford Biomedica Solutions contact info: Phone number: +14********* Website: https://oxbsolutions.com
Answer: Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (Oxford Biomedica or the Group), and Homology Medicines, Inc. (Nasdaq: FIXX) (Homology). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homologys innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Groups know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients lives worldwide.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month